13 Best Low Priced Growth Stocks to Invest In Right Now
The Russell 2000 entered a correction on October 14 as inflation worries hit stocks, Bloomberg reported, with the S&P 500 down 1.1% as a chip rout deepened.
Delcath Systems Inc. (DCTH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 83,980 | $1,341,161 | 0.01% | |
| 2. | Bailard Inc Thomas Bailard | 20,006 | $319,496 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.04 | 5,533 | $50,018.32 | 77,018 | 2026-03-06 | Filing | |
| $8.96 | 11,200 | $100,309.44 | 342,034 | 2026-03-02 | Filing | |
| $8.89 | 4,386 | $38,991.54 | 14,936 | 2025-11-21 | Filing | |
| $8.53 | 11,500 | $98,049.00 | 330,834 | 2025-11-11 | Filing | |
| $3.72 | 26,882 | $100,001.04 | 1,069,710 | 2024-03-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.75 | 34,606 | $129,789.80 | 150,000 | 2012-01-06 | Filing | |
| $2.47 | 10,000 | $24,660.00 | 631,294 | 2011-12-23 | Filing | |
| $2.44 | 10,000 | $24,421.00 | 641,294 | 2011-12-22 | Filing | |
| $2.00 | 10,000 | $20,000.00 | 651,294 | 2011-12-21 | Filing | |
| $1.95 | 10,000 | $19,500.00 | 661,294 | 2011-12-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 822,901 | $13,144,640 | 0% | |
| 2. | 314,903 | $5,028,518 | 0% | |
| 3. | 227,679 | $3,636,034 | 0.06% | |
| 4. | 170,335 | $2,720,249 | 0% | |
| 5. | 147,166 | $2,350,241 | 0% |
News See All
Delcath's (DCTH) Liver Cancer Device Keeps Growing, But At A Cost
On August 6, Delcath Systems (NASDAQ:DCTH) reported second-quarter results that showed the company selling more of its liver cancer treatment than ever, even as the cost of running the business climbed...
Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2026 Earnings Call Transcript
Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2026 Earnings Call Transcript May 7, 2026Delcath Systems, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.09714.
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 Earnings Call Transcript
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 Earnings Call Transcript February 26, 2026Delcath Systems, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.06299.
Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating
We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 9, Clear Street raised its price target on Delcath Systems, Inc.
10 Best Long Term Healthcare Stocks to Buy
In this article, we will discuss 10 Best Long Term Healthcare Stocks to Buy.
Here's What Hit Delcath Systems (DCTH) in Q3
Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here.
10 Fast-Growing Small Cap Stocks to Buy According to Analysts
In this article, we will look at the 10 Fast-Growing Small Cap Stocks to Buy According to Analysts.
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2025 Earnings Call Transcript
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2025 Earnings Call Transcript November 4, 2025Delcath Systems, Inc. reports earnings inline with expectations.
Invesco Backs Delcath Systems (DCTH) on Expansion Potential
Delcath Systems, Inc. (NASDAQ:DCTH) is among the fastest growing small cap stocks to buy. Invesco Ltd. has expanded its position in Delcath Systems, Inc.
Hedge Fund Resource Center